Recombinant follicle-stimulating hormone: New biotechnology for infertility

Pharmacotherapy

Volumn 18, Issue 5, 1998, Pages 1001-1010

  Prevost, Rebecca R ^a,b  

^a FLORIDA HOSPITAL   (United States)

^b Celebration Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UROFOLLITROPIN;

AMINO ACID SEQUENCE; AREA UNDER THE CURVE; CHO CELL; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG COST; DRUG HALF LIFE; EMBRYO TRANSFER; ERYTHEMA; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GAMETE INTRAFALLOPIAN TRANSFER; HEMATOMA; HUMAN; INFERTILITY THERAPY; INJECTION PAIN; INTRACYTOPLASMIC SPERM INJECTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAUTERINE INSEMINATION; MALE; MALE INFERTILITY; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

CLINICAL TRIALS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; RECOMBINANT PROTEINS;

EID: 0031681227     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Jones HW, Toner JP. The infertile couple. New Engl J Med 1993;329:1710-15.
2. Devroey P, Ubaldi F, Smitz J, Van Steirteghem A. Recombinant follicle stimulating hormone. Assist Reprod Rev 1994;4:2-9.
3. Loumaye E, Porchet HC, Beltrami V, et al. Ovulation induction with recombinant human follicle-stimulating hormone and luteinizing hormone. In: Filicori M, Flamigni C, eds. Ovulation induction: basic science and clinical advances. Proceedings of the symposium on ovulation induction: basic science and clinical advances. Amsterdam: Excerpta Medica, 1994;227-36.
4. Shoham Z, Insler V. Recombinant technique and gonadotropin production: new era in reproductive medicine. Fertil Steril 1996;66:187-201.
5. Olijve W, de Boer W, Julders JWM, van Wezenbeek PMGF. Molecular biology and biochemistry of human recombinant follicle stimulating hormone. Hum Reprod 1996;11(suppl 1):1-12.
6. DeLeeuw R, Mulders J, Voortman G, et al. Structure-function relationship of recombinant follicle stimulating hormone (Puregon). Hum Reprod 1996;11(suppl 1):13-21.
7. Geurts TBP, Peters MJH, vanBruggen JGC, et al. Puregon (Org 32489) - recombinant human follicle-stimulating hormone. Drugs Today 1996;32:239-58.
8. Mannaerts B, Shoham Z, Schoot D, et al. Single-dose pharmacokinelics and pharmacodynamics of recombinant follicle-stimulating hormone (Org 32489) in gonadotropin-deficient volunteers. Fertil Steril 1993;59:108-14.
9. Mannaerts B, Fauser B, Lahlou N, et al. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril 1996;65:406-10.
10. le Cotonnec JY, Porchet HC, Beltrami V, et al. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH. Fertil Steril 1994;61:669-78.
11. Mannaerts BMJL, Rombout F, Out HJ, Bennink HC. Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy. Hum Reprod 1996;11(suppl 1):22-30.
12. Out HJ, Reimitz PE, Coelingh Bennink HJT. A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon). Fertil Steril 1997;67:278-83.
13. Mannaerts B, de Leeuw R, Geelen J, et al. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology 1991;129:2623-30.
14. Matikainen T, deLeeuw R, Mannaerts B, Huhtaniemi I. Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects. Fertil Steril 1994;61:62-9.
15. Schoot DC, Harlin J, Shoham Z, et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotropin-deficient women. Hum Reprod 1994;9:1237-42.
16. Schoot DC, Coelingh Bennink HJT, Mannaerts BMJL, et al. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J Clin Endocrin Metab 1992;74:1471-3.
17. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT. Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Hum Reprod Update 1996;2:162-71.
18. Devroey P, Mannaerts B, Smitz J, el al. Clinical outcome of a pilot efficacy study on recombinant human follicle stimulating hormone (Org 32489) combined with various gonadotropin releasing hormone agonist regimens. Hum Reprod 1994;9:1064-9.
19. Jansen CAM, Van Os HC. Puregon without analogs: an oxymoron. Gynecol Endocrinol 1996;10(suppl 1):34.
20. Hedon B, Out HJ, Hugues JN, et al. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind multicentre trial. Hum Reprod 1995;10:3102-6.
21. Fisch B, Avrech OM, Pinkas H, el al. Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative study. J Assist Reprod Genet 1995;12:26-31.
22. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534-40.
23. Out HJ, Driessen SGAJ, Mannaerts BMJL, Ceolingh Bennink HJT. Recombinant follicle-stimulating hormone (follitropin β. Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertil Steril 1997;68:138-42.
24. Devroey P, van Steirteghem A, Mannaerts B, Coelingh Bennink HJT. Successful in vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet 1992;339:1170-1.
25. Devroey P, Mannaerts B, Smitz J, et al. First established pregnancy and birth after ovarian stimulation with recombinant human follicle stimulating hormone (Org 32489). Hum Reprod 1993;8:863-5.
26. Devroey P, van Steirteghem A, Mannaerts B, Coelingh Bennink HJT. First singleton term birth after ovarian superovulation with rhFSH. Lancet 1992;340:1108-9.
27. Homburg R, Giudice LC, Chang RJ. Polycystic ovary syndrome. Hum Reprod 1996;11:465-6.
28. Donderwinkel PFJ, Schoot DC, Coelingh Bennink HJT, Fauser BCJM. Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome. Lancet 1992;340:983.
29. Van Dessel HJHM, Donderwinkel PFJ, Coelingh Bennink HJT, Fauser BCJM. First established pregnancy and birth after induction of ovulation with recombinant human follicle-stimulating hormone in polycystic ovary syndrome. Hum Reprod 1994;9:55-6.
30. Phipps WR, Holden D, Sheehan RK. Use of recombinant human follicle-stimulating hormone for in vitro fertilization-embryo transfer after severe systemic immunoglobulin Emediated reaction to urofollitropin. Fertil Steril 1996;66: 148-50.
31. Organon Inc. Follistim (follitropin-β)) package insert. West Orange, NJ;1997.
32. McDonough PG. Recombinant follicle-stimulating hormone and luteinizing hormone - mimicking nature and beyond. Fertil Steril 1995;64:211-12.
33. Lapolt PS, Nishimori K, Fares FA, et al. Enhanced stimulation of follicle maturation and ovulatory potential by long-acting follicle stimulating hormone agonists with extended carboxyl-terminal peptides. Endocrinology 1992;131:2514-20.